3,146
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Green and chemically synthesized zinc oxide nanoparticles: effects on in-vitro seedlings and callus cultures of Silybum marianum and evaluation of their antimicrobial and anticancer potential

, , , , , , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 450-460 | Received 02 Nov 2020, Accepted 29 Apr 2021, Published online: 17 May 2021

Figures & data

Figure 1. Schematic illustration summarising the methodology and whole theme of the study.

Figure 1. Schematic illustration summarising the methodology and whole theme of the study.

Figure 2. (A) Control; (B) Plantlet treated with NP3; (C) Plantlet treated with NP2; (D) Plantlets treated with NP1.

Figure 2. (A) Control; (B) Plantlet treated with NP3; (C) Plantlet treated with NP2; (D) Plantlets treated with NP1.

Table 1. Effect of C-ZNPs and G-ZNPs on seed germination frequency and plantlets mean root and shoot lengths of S. marianum.

Table 2. Fresh and Dry weights of plantlets of S. marianum treated with different NPs.

Figure 3. Combined effect of different concentrations of PGRs and NPs-treated plantlets’ samples on DPPH activity in callus cultures in response to (a) 2BAP + 1NAA; (b) 5BAP + 1NAA; (c) 1TDZ; and (d) DPPH activity in response to in-vitro whole plantlets.

Figure 3. Combined effect of different concentrations of PGRs and NPs-treated plantlets’ samples on DPPH activity in callus cultures in response to (a) 2BAP + 1NAA; (b) 5BAP + 1NAA; (c) 1TDZ; and (d) DPPH activity in response to in-vitro whole plantlets.

Figure 4. Combined effect of different concentrations of PGRs and NPs-treated plantlets’ samples on TPC in callus cultures in response to (a) 2BAP + 1NAA; (b) 5BAP + 1NAA; (c) 1TDZ; and (d) TPC in response to in-vitro whole plantlets.

Figure 4. Combined effect of different concentrations of PGRs and NPs-treated plantlets’ samples on TPC in callus cultures in response to (a) 2BAP + 1NAA; (b) 5BAP + 1NAA; (c) 1TDZ; and (d) TPC in response to in-vitro whole plantlets.

Figure 5. Combined effect of different concentrations of PGRs and NPs-treated plantlets’ samples on TFC in callus cultures in response to (a) 2BAP + 1NAA; (b) 5BAP + 1NAA; (c) 1TDZ; and (d) TFC in response to in-vitro whole plantlets.

Figure 5. Combined effect of different concentrations of PGRs and NPs-treated plantlets’ samples on TFC in callus cultures in response to (a) 2BAP + 1NAA; (b) 5BAP + 1NAA; (c) 1TDZ; and (d) TFC in response to in-vitro whole plantlets.

Figure 6. Effect of different NPs in combination with different concentrations of BAP, NAA and TDZ on total protein content in (a) Stem, and (b) Root cultures of S. marianum.

Figure 6. Effect of different NPs in combination with different concentrations of BAP, NAA and TDZ on total protein content in (a) Stem, and (b) Root cultures of S. marianum.

Figure 7. Antibacterial activities of callus cultures and in-vitro plantlets grown on different PGRs and treated with C-ZNPs and G-ZNPs. From left to right i.e. (A1–A5) Antibacterial activity against K. pneumonia; (B1–B5) Antibacterial activity against B. subtilis; (C1–C5) Antibacterial activity against E. coli; (D1-D5) Antibacterial activity against L. monocytogenes. From top to bottom i.e. (A1, B1, C1, D1) Control of different bacterial strains; (A2, B2, C2, D2) 5BAP + 1NAA (1: NP1 stem; 2: NP2 root; 3: NP2 stem; 4: NP3 stem; 5: NP3 root); (A3, B3, C3, D3) 2BAP + 1NAA (6: NP1 root; 7: NP2 root; 8: NP2 stem; 9: NP3 root; 10: NP1 stem); (A4, B4, C4, D4) 1TDZ (11: NP1 root; 12: NP1 stem; 13: NP2 root; 14: NP2 stem; 15: NP3 root); (A5, B5, C5, D5) in-vitro plantlets (26: NP2; 27: C-ZNPs; 28: Control; 29: callus-synthesised NPs).

Figure 7. Antibacterial activities of callus cultures and in-vitro plantlets grown on different PGRs and treated with C-ZNPs and G-ZNPs. From left to right i.e. (A1–A5) Antibacterial activity against K. pneumonia; (B1–B5) Antibacterial activity against B. subtilis; (C1–C5) Antibacterial activity against E. coli; (D1-D5) Antibacterial activity against L. monocytogenes. From top to bottom i.e. (A1, B1, C1, D1) Control of different bacterial strains; (A2, B2, C2, D2) 5BAP + 1NAA (1: NP1 stem; 2: NP2 root; 3: NP2 stem; 4: NP3 stem; 5: NP3 root); (A3, B3, C3, D3) 2BAP + 1NAA (6: NP1 root; 7: NP2 root; 8: NP2 stem; 9: NP3 root; 10: NP1 stem); (A4, B4, C4, D4) 1TDZ (11: NP1 root; 12: NP1 stem; 13: NP2 root; 14: NP2 stem; 15: NP3 root); (A5, B5, C5, D5) in-vitro plantlets (26: NP2; 27: C-ZNPs; 28: Control; 29: callus-synthesised NPs).

Table 3. Antibacterial zones of inhibition (mm) of callus and in-vitro plantlets-derived C-ZNPs and G-ZNPs.

Figure 8. Anticancer activity of S. marianum-derived callus treated with C-ZNPs and G-ZNPs against HepG2 cells. (A) Non-treated cells (Negative control); (B) Doxorubicin (Positive control); (C) NP1 Root; (D) NP1 Stem; (E) NP2 Root; (F) NP2 Stem; (G) NP3 Root; (H) NP3 Stem.

Figure 8. Anticancer activity of S. marianum-derived callus treated with C-ZNPs and G-ZNPs against HepG2 cells. (A) Non-treated cells (Negative control); (B) Doxorubicin (Positive control); (C) NP1 Root; (D) NP1 Stem; (E) NP2 Root; (F) NP2 Stem; (G) NP3 Root; (H) NP3 Stem.